It’s not a great time to try and persuade jaundiced investors to part with cash for alternative proteins, observes Nosh.bio cofounder and CEO Tim Fronzek. But they’ll be hard-pressed to “find another company in the food space that has developed so fast in only two years,” he observes.
“By the end of this year, when we start running our own production site, we will be one of the biggest mycelium producers in the world,” claims Fronzek, who has already struck deals with two…
Read More…
‘We’re making a meat analog from a single ingredient’
